Neoadjuvant immunochemotherapy Clinical Trials
4 recruitingDrug
Phase 22Phase 31
Showing 1–4 of 4 trials
Recruiting
Phase 2
Surufatinib in Combination With Neoadjuvant Chemo-immunotherapy and Concurrent Chemoradiotherapy for Patients With Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell CarcinomaChemoradiotherapyToripalimab+2 more
Sun Yat-sen University69 enrolled1 locationNCT07086469
Recruiting
Phase 2
Neoadjuvant Immunochemotherapy for Locally Advanced Cervical Cancer: a Prospective, Single-arm, Phase II Clinical Trial
Cervical Cancers
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University34 enrolled1 locationNCT07003620
Recruiting
Neoadjuvant Treatment Real-world Clinical Outcomes in NSCLC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences1,500 enrolled1 locationNCT05974007
Recruiting
Phase 3
Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal Carcinoma
Esophageal CancerSurgeryNeoadjuvant Treatment+1 more
Henan Cancer Hospital400 enrolled1 locationNCT04280822